Cancer care at home could be a boon for health systems that own home-infusion companies, but it would challenge most physician-owned practices. Oncologists are working with Penn Home Infusion Therapy to deliver several other cancer therapies at home. Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, believes that up to 10%-20% of cancer patients may be eligible for home treatment in the future. For that to happen, however, payers will have to find ways to incentivize oncologists to choose home infusion, Bekelman said. Read more at Medscape.